Moderna was dealt a significant blow in the patent battle over who owns the Covid-19 vaccine last week. In the U.S., the Cambridge drug and vaccine maker hit a roadblock when the Patent Trial and ...

“The companies told the PTAB in the petitions that Moderna’s patents include ‘unimaginably broad claims directed to a basic idea.’” Patent Trial and Appeal Board (PTAB) docket entries ...

March 5 - Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab won a round in their legal battle with Moderna (MRNA.O), opens new tab over COVID-19 vaccine patents on Wednesday ...

The second vaccine, developed by Moderna in partnership with the National Institute of Allergy and Infectious Diseases, got the greenlight from the FDA days later. These steps are now overlapping ...

MORE: Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS The opposition comes at a critical juncture because vaccines using mRNA have applications well beyond ...